Home » Topics » BioWorld Science

BioWorld Science
RSS

Luye Pharma initiates phase III trial of LY03005 in China

June 15, 2018

Faron Pharmaceuticals presents biomarker analysis of the phase III INTEREST trial

June 15, 2018

Apexigen and Yale Cancer Center enter a clinical collaboration

June 15, 2018

Searching for a biomarker for microbiome rehabilitation in recurrent C. difficile infections

June 15, 2018

Phase II results presented from KEYNOTE-158 study of pembrolizumab in SCLC

June 14, 2018

Allos initiates phase I RSV challenge study with JNJ-64417184

June 14, 2018

Verseon prepares for phase I study of oral anticoagulant VE-1902

June 14, 2018

Long-term articular cartilage structure modification seen with sprifermin in knee osteoarthritis

June 14, 2018

Subcutaneous efgartigimod has comparable characteristics to intravenous formulation in phase I study

June 14, 2018

Sun BioPharma announces dosing of first patients in second clinical study of SBP-101

June 14, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...